a) Induction and maintenance of remission of ulcerative colitis; treatment of active Crohn's Disease. b) Treatment of rheumatoid arthritis which has failed to respond to non-steroidal anti-inflammatory drugs (NSAIDs).
Induction and maintenance of remission of ulcerative colitis; treatment of active Crohn's Disease.
Ulcerative colitis or Crohn's Disease affecting the rectum.
The FDA has approved Zydelig (idelalisib), from Gilead Sciences, for the treatment of three B-cell blood cancers: as 150mg tabs,...
Pyridoxine is indicated for adults and children over 12 years old in the treatment of isoniazid-induced peripheral neuritis and pyridoxine deficiency states.